Oral administration of Hsp65‐producing Lactococcus lactis attenuates allergic asthma in a murine model

L.B. Lacerda,W.M. Rios,A.P. Masson,I.T. Brandão,T.M. Milani,M.C. Borges,L.N.Z. Ramalho,M.C.R. Barbosa,A. Miyoshi,C.L. Silva
DOI: https://doi.org/10.1111/jam.14913
2020-11-22
Journal of Applied Microbiology
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aims</h3><p>Allergic asthma is a chronic inflammatory lung disease characterised by a Th2‐type immune response pattern, and the development of nonspecific immunotherapy is one of the primary goals for the control of this disease.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods and Results</h3><p>In this study, we evaluated the therapeutic effects of <i>L. lactis</i>‐producing mycobacterial heat shock protein 65 (LLHsp65) in an ovalbumin (OVA)‐induced allergic asthma model. OVA‐challenged BALB/c mice were orally administrated with LLHsp65 for ten consecutive days. The results demonstrate that LLhsp65 attenuates critical features of allergic inflammation, like airway hyperresponsiveness and mucus production. Likewise, the treatment decreases the pulmonary eosinophilia and the serum level of OVA‐specific IgE. In addition to deviating immune responses toward Th1‐cytokine profile and increase the production of regulatory cytokines, such as IL‐6 and IL‐10. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our results reveal that the mucosal immunotherapy of LLHsp65 significantly reduces the overall burden of airway allergic inflammation, suggesting a promising therapeutic strategy for the treatment of allergic asthma.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Significance and Impact of Study</h3><p>This research reveals new perspectives on nonspecific immunotherapy based on the delivery of recombinant proteins by lactic acid bacteria for the treatment of allergic disorders.</p></section>
microbiology,biotechnology & applied microbiology
What problem does this paper attempt to address?